SCHEMBL17039628

SCHEMBL17039628

CCOC(=O)CCN(C(=O)c1ccc(NC)c(NC(=O)CNc2ccc(C#N)cc2)c1)c1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.49
ALDH1A1 P00352 6/20 0.43
GAA P10253 5/20 0.43
MAPK1 P28482 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
F2 P00734 5/20 0.43
NR1I2 O75469 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
SLC6A2 P23975 1/20 0.43
AGTR1 P30556 1/20 0.43
SLC6A3 Q01959 1/20 0.43
SCN5A Q14524 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SLC22A2 O15244 1/20 0.38
F10 P00742 1/20 0.38
PLG P00747 1/20 0.38
PLAT P00750 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15427687 0.83 ALDH1A1 (0.56) NQO2ALDH1A1GAAMAPK1MEN1
SCHEMBL505830 0.81 KMT2A (0.40) ALDH1A1GAAMEN1KMT2AF2
SCHEMBL6776351 0.81 ALDH1A1 (0.47) NQO2ALDH1A1GAAMAPK1MEN1
SCHEMBL17039629 0.81 NQO2 (0.51) NQO2ALDH1A1GAAMAPK1MEN1
Ethyl Propionate SCHEMBL28977492 0.80 NPC1 (0.41) ALDH1A1GAAMAPK1MEN1KMT2A
SCHEMBL17546280 0.79 ALDH1A1 (0.58) NQO2ALDH1A1GAAMAPK1MEN1
SCHEMBL17052609 0.78 NQO2 (0.42) NQO2ALDH1A1GAAMAPK1MEN1
SCHEMBL15562472 0.77 NQO2 (0.56) NQO2ALDH1A1GAAMAPK1MEN1
SCHEMBL15562470 0.77 NQO2 (0.57) NQO2ALDH1A1GAAMAPK1MEN1
SCHEMBL1269634 0.77 NQO2 (0.54) NQO2ALDH1A1GAAMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116239572-A Preparation method of dabigatran etexilate intermediate 宿迁盛基医药科技有限公司 2023-06-09 CN disclosed
CN-110128407-B Preparation method of dabigatran etexilate key intermediate 连云港恒运药业有限公司 2022-04-01 CN disclosed
WO-2015124764-A1 SYNTHESIS PROCESS OF DABIGATRAN ETEXILATE MESYLATE, INTERMEDIATES OF THE PROCESS AND NOVEL POLYMORPH OF DABIGATRAN ETEXILATE ERREGIERRE S.P.A. (IT) 2015-08-27 WO disclosed